Ozempic and Wegovy officially moved off FDA's drug shortage list

Ozempic and Wegovy, the widely popular forms of semaglutide sold to treat diabetes and obesity, have officially been removed from the Food and Drug Administration's (FDA) drug shortage list nearly four months after the agency found the drugs to be available. The FDA's drug shortage list now states that as of Feb. 21, 2025, the...

No comments

Read more